northwest China's Shaanxi Province, Dec. 19, 2022. Many pharmaceutical companies in China are working at full capacity to increase the medicine supply as the country continues to optimize COVID-19 epidemic prevention and control measures. (Photo by Zou Jingyi/Xinhua) ...
is one of the largest pharmaceutical companies in China. It produces and sells a variety of Chinese medicines and chemical drugs. The company also involves in property management, E-commerce, and other businesses.
Industry & Market Breakdown of pharmaceutical industry revenue in China 2021, by segment Industry & Market Largest Chinese pharmaceutical companies 2023, by sales value Recommended statistics Key Figures Drug evaluation and approval Sales channels Pharmaceutical enterprisesKey...
According to the annual ranking of Forbes Global 2000 which measures the world's largest public companies, Sinopharm Group ranked first among the top Chinese pharmaceutical companies in terms of sales value in 2023, amounting to approximately 82 billion U.S. dollars. Shanghai Pharmaceuticals took th...
into global development and commercialization agreements. The two companies will jointly develop these ADC drug candidates for potential global commercialization, and Daiichi Sankyo will retain exclusive rights and be solely responsible for the manufacturing and supply of the three drug candidates in Japan...
SFDA required all pharmaceutical companies in China to obtain GMP certificates from SFDA by June 30, 2004 to be licensed to sell their drug products in China. About 3000 of the companies met the deadline; companies in the process of obtaining certification may subcontract secondary production to ...
Moreover, China's pharmaceutical companies have significantly increased their efforts to expand into Africa, aiming to provide more affordable medicines and healthcare solutions to the continent. Globally, in 2022, there were an estimated 249 million malaria cases and 608,000 malaria deaths, respective...
Blockbuster product development and the merger of major drug firms characterize the current state of the global pharmaceutical industry. The next wave of structural changes is now under way with multinational corporations (MNCs) setting up new facilities in Asia as well as contracting out services to...
marketintheworldby2011.[2]ResearchanddevelopmentisrapidlyincreasingwithShanghaibecomingoneofthemostimportantglobalcenters.Mostnotably,NovartisisexpectedtoestablishalargeR&DbaseinShanghaithatwillbeapillarofitsdrugdevelopment.[3]China'sthousandsofdomesticcompaniesaccountfor70%ofthemarket,andthetop10companiesabout20%,...
Qilu Pharmaceutical is one of the leading vertically integrated pharmaceutical companies in China focusing on the development, manufacturing and marketing of active pharmaceutical ingredients (APIs) & finished formulations. Qilu currently has 12 subsidiaries, 11 manufacturing sites and over 39,000 employees...